|
Lunit highlights enterprise AI adoption and FDA-cleared advancements at SBI 2026
SEOUL, South Korea, April 16, 2026 /PRNewswire/ -- At the Society of Breast Imaging (SBI) Annual Symposium, Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced accelerating clinical adoption across the U.S., a full-scale enterprise deployment of its AI-powered breast cancer ecosystem, and FDA clearance of its next-generation 3D mammography AI.
Lexington Clinic Adopts Full Breast Cancer Ecosystem
Lexington Clinic, Central Kentucky's largest and oldest physician-owned multi-specialty medical group (serving more than 350 providers), has implemented Lunit's complete AI-powered breast cancer ecosystem.
The deployment spans:
- Detection with Lunit INSIGHT® Breast Suite for mammography (MMG) and digital breast tomosynthesis (DBT)
- Quality optimization with Analytics™ and Volpara® Live™
- Volumetric breast density assessment with Volpara® Scorecard™
- Risk assessment with Risk Pathways™, integrated into clinical workflows
- Mammography tracking with Patient Hub™
The implementation signals a shift toward end-to-end AI integration across the breast care continuum—from risk to detection to quality—within a single software suite.
"Our goal is to deliver the highest standard of care while keeping workflows efficient and consistent," said Angie Hall, Breast Center Manager at Lexington Clinic. "Bringing risk, detection, and quality into one ecosystem improves coordination across our team and supports more confident, earlier decision-making for every patient."
Adoption Across the Americas Surpasses 330 Sites
Over the past year, Lunit has expanded to more than 330 screening sites across the Americas, supporting approximately one million screening mammograms annually.
The milestone highlights a broader industry shift: while AI validation is well established, real-world adoption at scale is now the key differentiator.
"Across the Americas, we're seeing a clear move from evaluation to enterprise-wide implementation," said Craig Hadfield, CEO of Lunit International. "Providers are moving beyond pilots into daily clinical use. Reaching more than 330 sites and supporting one million screenings annually reflects sustained, real-world adoption—where AI is delivering value in routine practice."
Real-World Clinical Impact: Radiology Consultants of Iowa
At Radiology Consultants of Iowa (RCI), one of the largest radiology groups in the state, Lunit INSIGHT DBT is already embedded in routine clinical workflows, demonstrating the impact of AI beyond the study setting.
"After six months of using AI in our daily workflow, it's become part of how we read," said Robert J. Dolan, DO, breast imaging specialist at RCI. "It gives us added confidence—especially in subtle cases—and helps ensure we don't miss what matters most."
At SBI, Dr. Dolan will review cases each day in Lunit's booth, highlighting where AI positively impacts his interpretation, giving attendees a chance to discuss real-world adoption.
FDA Clearance of Next-Generation 3D AI with Current-Prior Comparison
As providers move into routine AI use, flexibility in how algorithms are deployed is becoming increasingly important. Lunit announced that Version 1.2 of its 3D mammography algorithm has received clearance from the U.S. Food and Drug Administration (FDA).
The updated version introduces current-prior comparisons and multiple operating thresholds, enabling providers to tailor AI performance to their clinical environment.
Key enhancements include:
- Current-prior comparison (CPC) provides AI findings for the current exam and up to two prior exams
- Three selectable thresholds, supporting different sensitivity and specificity trade-offs
- Access to Volpara® Scorecard™ volumetric breast density measures along with AI scores
These updates reinforce Lunit's focus on practical usability—giving clinicians greater control over how AI is applied in daily practice.
###
About Lunit
Founded in 2013, Lunit (KRX: 328130) is a global leader on a mission to conquer cancer through AI. Our clinically validated solutions span medical imaging, breast health, and biomarker analysis—empowering earlier detection, smarter treatment decisions, and more precise outcomes across the cancer care continuum.
Lunit offers a comprehensive suite spanning risk prediction and early detection to precision oncology. Our FDA-cleared Lunit INSIGHT Breast Suite and breast health solutions support cancer screening in thousands of medical institutions worldwide, while the Lunit SCOPE platform is used in research partnership with global pharma and laboratory leaders for biomarker research, and companion diagnostic development.
Trusted by over 10,000 sites in more than 65 countries, Lunit combines deep medical expertise with continuously evolving datasets to deliver measurable impact—for patients, clinicians, and researchers alike. Headquartered in Seoul with global offices, Lunit is driving the worldwide fight against cancer. Learn more at lunit.io.
Lunit highlights enterprise AI adoption and FDA-cleared advancements at SBI 2026
SEOUL, South Korea, April 16, 2026 /PRNewswire/ -- At the Society of Breast Imaging (SBI) Annual Symposium, Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced accelerating clinical adoption across the U.S., a full-scale enterprise deployment of its AI-powered breast cancer ecosystem, and FDA clearance of its next-generation 3D mammography AI.
Lexington Clinic Adopts Full Breast Cancer Ecosystem
Lexington Clinic, Central Kentucky's largest and oldest physician-owned multi-specialty medical group (serving more than 350 providers), has implemented Lunit's complete AI-powered breast cancer ecosystem.
The deployment spans:
- Detection with Lunit INSIGHT® Breast Suite for mammography (MMG) and digital breast tomosynthesis (DBT)
- Quality optimization with Analytics™ and Volpara® Live™
- Volumetric breast density assessment with Volpara® Scorecard™
- Risk assessment with Risk Pathways™, integrated into clinical workflows
- Mammography tracking with Patient Hub™
The implementation signals a shift toward end-to-end AI integration across the breast care continuum—from risk to detection to quality—within a single software suite.
"Our goal is to deliver the highest standard of care while keeping workflows efficient and consistent," said Angie Hall, Breast Center Manager at Lexington Clinic. "Bringing risk, detection, and quality into one ecosystem improves coordination across our team and supports more confident, earlier decision-making for every patient."
Adoption Across the Americas Surpasses 330 Sites
Over the past year, Lunit has expanded to more than 330 screening sites across the Americas, supporting approximately one million screening mammograms annually.
The milestone highlights a broader industry shift: while AI validation is well established, real-world adoption at scale is now the key differentiator.
"Across the Americas, we're seeing a clear move from evaluation to enterprise-wide implementation," said Craig Hadfield, CEO of Lunit International. "Providers are moving beyond pilots into daily clinical use. Reaching more than 330 sites and supporting one million screenings annually reflects sustained, real-world adoption—where AI is delivering value in routine practice."
Real-World Clinical Impact: Radiology Consultants of Iowa
At Radiology Consultants of Iowa (RCI), one of the largest radiology groups in the state, Lunit INSIGHT DBT is already embedded in routine clinical workflows, demonstrating the impact of AI beyond the study setting.
"After six months of using AI in our daily workflow, it's become part of how we read," said Robert J. Dolan, DO, breast imaging specialist at RCI. "It gives us added confidence—especially in subtle cases—and helps ensure we don't miss what matters most."
At SBI, Dr. Dolan will review cases each day in Lunit's booth, highlighting where AI positively impacts his interpretation, giving attendees a chance to discuss real-world adoption.
FDA Clearance of Next-Generation 3D AI with Current-Prior Comparison
As providers move into routine AI use, flexibility in how algorithms are deployed is becoming increasingly important. Lunit announced that Version 1.2 of its 3D mammography algorithm has received clearance from the U.S. Food and Drug Administration (FDA).
The updated version introduces current-prior comparisons and multiple operating thresholds, enabling providers to tailor AI performance to their clinical environment.
Key enhancements include:
- Current-prior comparison (CPC) provides AI findings for the current exam and up to two prior exams
- Three selectable thresholds, supporting different sensitivity and specificity trade-offs
- Access to Volpara® Scorecard™ volumetric breast density measures along with AI scores
These updates reinforce Lunit's focus on practical usability—giving clinicians greater control over how AI is applied in daily practice.
###
About Lunit
Founded in 2013, Lunit (KRX: 328130) is a global leader on a mission to conquer cancer through AI. Our clinically validated solutions span medical imaging, breast health, and biomarker analysis—empowering earlier detection, smarter treatment decisions, and more precise outcomes across the cancer care continuum.
Lunit offers a comprehensive suite spanning risk prediction and early detection to precision oncology. Our FDA-cleared Lunit INSIGHT Breast Suite and breast health solutions support cancer screening in thousands of medical institutions worldwide, while the Lunit SCOPE platform is used in research partnership with global pharma and laboratory leaders for biomarker research, and companion diagnostic development.
Trusted by over 10,000 sites in more than 65 countries, Lunit combines deep medical expertise with continuously evolving datasets to deliver measurable impact—for patients, clinicians, and researchers alike. Headquartered in Seoul with global offices, Lunit is driving the worldwide fight against cancer. Learn more at lunit.io.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Lunit Surpasses 330+ Sites and 1M Annual Screenings as Breast Imaging AI Moves into Clinical Practice
TVU RPS platform opens a new path to super slo-mo for more collegiate sports while serving as a resilient backup to fiber and an early-venue connectivity solution
CUPERTINO, Calif., April 16, 2026 /PRNewswire/ -- TVU Networks today announced that Big Ten Network (BTN) is using the TVU Remote Production System (RPS) platform to bring super slow-motion replay to a broader range of collegiate sports—extending the capability beyond football and basketball to events like baseball, soccer, and volleyball. BTN has also expanded the role of TVU RPS Link encoders in its field production trucks, using them as a hot backup to fiber-based workflows and as an early access network that provides connectivity before venue fiber is even activated.
BTN's football and basketball productions already rely on established, high-end replay workflows. But fans increasingly expect the same caliber of 3x, 4x, and 6x super slo-mo replays from a collegiate wrestling match or soccer game. Until now, the synchronization demands of high-speed replay cameras made that impractical for events without dedicated fiber infrastructure, or having replay hardware on site, which isn't practical for all events. The TVU RPS platform now gives BTN a new option to extend super slo-mo to more sports and more venues—complementing its existing production model rather than replacing it.
TVU RPS units at each venue encode multiple super slo-mo camera feeds and transport them over standard internet, 5G, or Starlink connections to BTN's central production hub, where they arrive perfectly synchronized with zero drift. The hub's Evertz DreamCatcher replay servers then create the super slo-mo content viewers see on air. TVU's synchronization has proven stable over multi-day continuous operation—a level of precision that competing transport solutions have been unable to match, often drifting or requiring manual resets that disrupt live coverage.
"The primary hurdle for moving our super slo-mo workflows to a remote model has always been the synchronization drift over the open internet," said Nick Smith, VP of Engineering, Big Ten Network. "TVU has allowed us to take super slo-mo replay where it wasn't previously possible."
For these additional sports, the system also gives BTN full remote control of cameras in the field. From the central studio, operators can adjust cameras, manage tally and intercom, and produce shows across different venues without anyone traveling—allowing BTN to extend its production quality to more events without scaling up on-site crews.
Separately, BTN has also integrated TVU RPS Link units into its regional field trucks as a hot backup for its existing fiber-based productions at major events. If the primary fiber connection fails, the TVU system seamlessly takes over, maintaining the synchronized super slo-mo feeds. The units also run TVU Router, which provides immediate high-speed connectivity to production trucks before venue fiber is activated—giving crews operational access from the moment they arrive on site.
"Big Ten Network's implementation is a brilliant example of total network orchestration," said Matt McEwen, VP of Product Management, TVU Networks. "They saw an opportunity to use TVU RPS to bring super slo-mo to more sports and more venues, while also adding resilience and flexibility to their existing fiber-based productions. It's a smart, layered approach, and we're proud to support their vision for expanding what's possible in collegiate sports production."
To learn more about how TVU allows broadcasters to deploy elite slo-mo capabilities at any venue, download the white paper: Super Slo-Mo Anywhere: The Democratization of Elite Sports Production via TVU's Bonded RPS REMI Ecosystem.
ABOUT TVU NETWORKS
TVU Networks is a global leader in cloud and IP-based live video solutions, powering broadcast, streaming, and remote production for news, sports, and entertainment. Trusted by media organizations in over 100 countries, TVU's award-winning ecosystem enables agile, scalable, and cost-effective workflows, anytime, anywhere. For more information, visit www.tvunetworks.com
Media Contact
Jessica Mintz
VP Marketing & Communications
TVU Networks
jmintz@tvunetworks.com
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Big Ten Network Expands Super Slo-Mo Replay to More Sports with TVU Networks; Establishes Bonded IP as Critical Hot Backup and Early Access Network
